Insider · CIK 0001872772
Lin Wei
Files at RVMD (Revolution Medicines, Inc.), TSVT (2seventy bio, Inc.). First filing Jun 18, 2025, latest Mar 19, 2026.
Lin Wei files SEC Form 4 as director and officer at RVMD (Revolution Medicines, Inc.), and also at TSVT (2seventy bio, Inc.). Since Jun 18, 2025, Lin Wei has reported 0 open-market buys worth $0 and 3 open-market sells worth $392k, the latest filed on Mar 19, 2026.
A track record needs three past buys with six months of prices behind them; Lin Wei has 0, so none is measured yet.
The newest scored trade: sold $206k of RVMD on Mar 17, 2026, filed Mar 19, 2026, scored 22 (weak), under a 10b5-1 plan. In the last 12 months: 0 buys worth $0 and 1 sell worth $206k.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
RVMD: Revolution Medicines, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 22Weak | Revolution Medicines, Inc. | $206k 2,073 shares | -2% | +218% from low-20% from high | |
| 20Weak | Revolution Medicines, Inc. | $99k 2,160 shares | -2% | +44% from low-26% from high | |
| 19Weak | Revolution Medicines, Inc. | $87k 2,173 shares | -2% | +28% from low-34% from high |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Mar 13, 2026 | RVMD Revolution Medicines, Inc. | 2,288 0.00% of outstanding | $228k | Mar 16, 2026 | none |
| Sep 15, 2025 | RVMD Revolution Medicines, Inc. | 2,131 0.00% of outstanding | $99k | Sep 15, 2025 | $87k |
| Jun 13, 2025 | RVMD Revolution Medicines, Inc. | 2,131 0.00% of outstanding | $87k | Jun 16, 2025 | none |
Transactions
Every row this insider has filed, 8 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 17, 2026 | RVMD Revolution Medicines, Inc. | SOpen-market sale Common Stock10b5-1 | -2,073 | $99.48 | $206k | 101,366 | Mar 19, 2026 |
| Mar 1, 2026 | RVMD Revolution Medicines, Inc. | AGrant or award Common Stock | +15,100 | $0.00 | $0 | 103,439 | Mar 3, 2026 |
| Mar 1, 2026 | RVMD Revolution Medicines, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +34,000 | $0.00 | $0 | 34,000 | Mar 3, 2026 |
| Sep 16, 2025 | RVMD Revolution Medicines, Inc. | SOpen-market sale Common Stock10b5-1 | -2,160 | $45.82 | $99k | 88,339 | Sep 18, 2025 |
| Jun 16, 2025 | RVMD Revolution Medicines, Inc. | SOpen-market sale Common Stock10b5-1 | -2,173 | $39.83 | $87k | 90,499 | Jun 18, 2025 |
| May 13, 2025 | TSVT 2seventy bio, Inc. | DDisposition to issuer Common Stock | -17,583 | - | - | 15,267 | May 15, 2025 |
| May 13, 2025 | TSVT 2seventy bio, Inc. | UTender of shares Common Stock | -15,267 | - | - | 0 | May 15, 2025 |
| May 13, 2025 | TSVT 2seventy bio, Inc. | DDisposition to issuer Stock Options (Right to buy)derivative | -24,100 | - | - | 0 | May 15, 2025 |
Questions about Lin Wei
Answered from the filings on this page, as of the latest one.
Is Lin Wei buying or selling?
In the last 12 months Lin Wei reported 0 open-market buys worth $0 and 1 open-market sell worth $206k on SEC Form 4; the latest was sold $206k of RVMD on Mar 17, 2026. Grants, option exercises and tax withholding are not counted.
How did Lin Wei's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Lin Wei has 0.
Where does Lin Wei file Form 4?
Lin Wei has filed Form 4 at RVMD (Revolution Medicines, Inc.) as Chief Medical Officer; TSVT (2seventy bio, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.